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INTRODUCTION
T cells with regulatory properties are critical to the induction of self-tolerance and acquired tolerance 1, 2 . Among the cell types that exhibit potent suppressor functions, the CD4 + Foxp3 + regulatory T cells (Tregs) are particularly important as deficiency or functional impairment of this cell type often leads to the development of autoimmunity and the failure to establish acquired tolerance 3, 4 , albeit other regulatory cell types also contribute to tolerance via different mechanisms 5 .
The CD4 + Foxp3 + T REGS are not a uniform cell type. Depending on the origin of these cells, the CD4 + Foxp3 + T cells can be divided into those that are developed in the thymus (natural T REGS ) and those that are induced in the periphery (induced T REGS ) 6 . Natural Foxp3 + T REGS are selected and matured in the thymus, and then exported to the periphery where they suppress potentially cytopathic T cells 7 . It is well known that lineage commitment of the natural Foxp3 + T REGS requires Foxp3 8, 9 , and their survival and expansion demand the presence of IL-2 and expression of IL-2 receptors 10 . However, some activated T effector cells can be converted to Foxp3 + T REGS in the periphery and such induced Foxp3 + T REGS also act as potent suppressor cells 11, 12 . From a therapeutic point of view, therapies that can preserve or expand the Foxp3 + Tregs and at the same time inhibit cytopathic T effector cells would be highly desirable in the induction of transplant tolerance or in the treatment of autoimmune diseases.
Phenotypically, Foxp3 + T REGS and activated T effector cells often express similar cell surface molecules. For example, both cell types express CD25, CD28, CD154, GITR, CTLA-4 etc., although the functions of such molecules are not always the same in both cell types 4 . Recently, it has been shown that the CD4 + CD25 + T REGS constitutively express OX40 (also called CD134) 13 , a new costimulatory molecule that belongs to the TNF-R superfamily 14 . Also, T effector cells, though do not express OX40 at resting state, can readily express OX40 upon activation 13 , and OX40 engagement delivers a potent costimulatory signal to T effector cells 15 . The recent finding that deliberately stimulating OX40 in vivo can break tolerance to peptide antigens 16 and that blocking OX40 costimulation can enable allograft survival in stringent transplant models 17 suggests that the impact of OX40 signaling on a regulatory type of immune response is likely to be profound. However, very little is known about the role of OX40 in regulating the 
MATERIALS AND METHODS

Animals
), Rag-1 -/-were purchased from The Jackson Laboratory (Bar Harbor, ME). Generation of OX40 -/-, OX40L -/-, and OX40Ltg mice, all of which are on the C57BL/6 background, has already been described 18, 20, 21 . Foxp3-gfp knockin mice (foxp3gfp.KI) on the C57BL/6 background were generated by introducing the bicistronic EGFP reporter gene into the Foxp3 locus and used as previously reported 22 . Foxp3gfp.KI mice that are deficient for OX40 were generated by crossing the foxp3gfp.KI mice with the OX40 
Monoclonal antibodies
The following anti-mouse mAbs used for cell surface staining were obtained from BD PharMingen (San Diego, CA): Cychrome-anti-CD4, PE-Cy5-anti-CD4 (clone GK1.5), PEanti-CD25 (clone PC61), PE-anti-OX40 (clone OX86), FITC-anti-CD90.1, PE-Annexin V, and isotype control Abs. Anti-mouse IFN-γ capturing antibody (clone R4-6A2), biotin-anti-IFN-γ detection antibody (clone XMG1.2), horseradish peroxidase (HRP)-streptavidin for ELISPOT assay were also obtained from BD PharMingen. A PE-anti-mouse Foxp3 mAb (clone FJK-16s) was purchased from eBiosciences (San Diego, CA).
An agonist anti-mouse OX40 mAb (clone OX86) and the anti-mouse CD154 (clone MR1)
were produced from hybridoma cell lines by BioExpress (West Lebanon, NH) and were used in some in vitro and in vivo studies.
Cell staining and flow cytometry
Spleen and lymph node cells were harvested and single cell suspension was prepared as previously reported 17 . Cells were resuspended in PBS/0.5% BSA and stained with fluorochrome-conjugated Abs on ice for 20 min. The cells were washed twice in PBS/BSA and fixed in 1% paraformaldehyde prior to FACS analysis. All samples were acquired using electronically gated, and then sorted using the MoFlo high speed cell sorter (Dako-Cytomation, Ft Collins, CO). The purity of cells sorted using this method was consistently >96% 23 . /mice). The host mice were then treated with a tolerizing protocol consisting of donor specific transfusion (DST) and anti-CD154 mAb 25 . Briefly, the host mice were injected with 
Preparation of APCs as stimulator cells
Skin transplantation
Full thickness tail skin grafts from donor mice were transplanted onto the thoracic wall of recipients as previously reported 17 . Graft survival was assessed by daily visual inspection and rejection was defined as a complete loss of viable tissue grafts. In some experiments, recipient mice were treated with an agonist anti-OX40 mAb (0.5 mg, i.p. on days 0, 2, 4, 8) following skin grafting and day 0 was the time of skin transplantation.
Statistics
Analysis of levels of Foxp3+ Tregs, cell proliferation, and ELISPOT data was performed using the student t test. Allograft survival was compared using the log-rank test. A p<0.05 was considered as significant.
RESULTS
OX40 is expressed by functionally different T cell subsets
To examine the cell types that express OX40, and therefore, are likely regulated by OX40 costimulation, we used a newly developed foxp3gfp.KI model in which the endogenous Foxp3 locus is genetically linked to the reporter protein EGFP 22 . In naïve foxp3gfp.KI mice, CD4 + GFP(Foxp3) + Tregs in either the spleen or the lymph nodes constitutively expressed OX40 on the cell surface, whereas the CD4 + GFP(Foxp3) − T effector cells did not (Fig. 1a) .
However, when CD4 + GFP(Foxp3) − T effector cells were FACS sorted and activated in vitro with anti-CD3 and anti-CD28, OX40 expression was readily induced on the cell surface ( (Fig 3b) . The converted GFP(Foxp3) + Tregs were FACS sorted and further examined in a secondary culture for their suppressor functions in vitro.
As shown in Fig 3c, (Fig 4b) . In these cultures, the CD4 + GFP(Foxp3) + Tregs alone did not proliferate at all when stimulated with anti-CD3 plus OX40Ltg APCs (Fig 4b) . (Fig 5b) .
We then used a skin transplant model to further examine whether OX40 stimulation would interfere with the Foxp3+ Treg-mediated suppression of skin allograft rejection in vivo. (Fig 4) , suggesting that the APCs (Fig 6c) . Thus, OX40 appears to be a negative regulator of Foxp3 expression in 43, 44 . Furthermore, studies using mice deficient for OX40 or OX40L
demonstrate that OX40 is also critical to the generation of memory T cells 45 . Our study suggests that suppression of de novo generation of new Foxp3 + Tregs by OX40 is likely to be an important mechanism by which OX40 promotes functional differentiation of T effector cells.
However, the precise molecular mechanisms by which OX40 directs Th1 and Th2 differentiation, and at the same time turns off Foxp3+ Tregs, especially in the context of T-bet and GATA3 expression, await further investigation. OX40 is known to play an important role in the transition of T effector cells to a memory phenotype 45 
